Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 6 (8), e108

Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation

Affiliations

Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation

Kelly Cushing et al. Clin Transl Gastroenterol.

Similar articles

See all similar articles

Cited by 21 articles

See all "Cited by" articles

References

    1. Harig JM, Soergel KH, Komorowski RA et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989; 320: 23–28. - PubMed
    1. Thibault R, Blachier F, Darcy-Vrillon B et al. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis 2010; 16: 684–695. - PubMed
    1. Furusawa Y, Obata Y, Fukuda S et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446–450. - PubMed
    1. Arpaia N, Campbell C, Fan X et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451–455. - PMC - PubMed
    1. Chang PV, Hao L, Offermanns S et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014; 111: 2247–2252. - PMC - PubMed
Feedback